Our mission is to introduce an innovative, high-quality intrauterine drug-delivery technology to improve and impact women’s health and quality of life
This Is What We Do
IUB™ Ballerine®, a safer1, hormone-free next generation “smart” IUD (long acting reversible contraceptive) that fits women’s anatomy.
IUB™ SEAD® (Spherical Endometrial Ablation Device), is a new paradigm in the treatment of Abnormal Uterine Bleeding (AUB) & Heavy Menstrual Bleeding (HMB): a novel, once-and-done, pain-free2 and safe solution.
IUB™ PRIMA®, a therapeutic-delivery to target therapy areas such as endometriosis and myomas as well as heavy menstrual bleeding and other hormonal solutions delivered directly through the uterus moving away from systemic side effects.
The World Economic Forum recognizes OCON Therapeutics as Technology Pioneer 2022 for creating new technologies and innovation that are poised to have a significant impact on business and society
Finally, women’s health products that are designed and managed by women for women that fit women’s anatomy and needs.
OCON’s platform technology excels in simplicity, safety, cost-effectiveness, new and innovative technology.
in the media
OCON Therapeutics has reached its recruitment goal of its Phase IIb clinical study evaluating the revolutionary IUB™ SEAD®, a non-invasive treatment for heavy menstrual bleeding affecting 1 in 3 women
March 24, 2023
OCON Therapeutics is honored to be part of Bolt PR’s (A Millwright Agency) important list of Femtech Brands and Innovations to watch in 2023
March 15, 2023
1 compared to literature of Traditional IUDs and ongoing vigilance reporting for IUB™ Ballerine, OCON Medical Ltd.
2 ongoing Phase II Clinical Studies, OCON Medical Ltd.